Skip to content
OpenCapital
Get started

PTC Therapeutics PTCT Business Segments — Program Spend

Similar metrics at other companies

STERIS logo
STELife Sciences: — R&D
$2.8M+16.7%
Danaher logo
DHRLife Sciences — Capital expenditures, gross
$27M-43.8%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Purchases of property, plant and equipment
$20M-53.5%
Revvity logo
RVTYLife Sciences — Segment research and development expenses
$31.62M+11.9%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Acquisitions
$525.25M-8.7%
GLW
GLWLife Sciences and Emerging Growth Businesses — CapEx
$5M-37.5%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E8×—
P/S7.9×+5.3×

Profitability

See full
Gross margin96%—
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%—
Debt / equity372.3×—
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept ptct:ProgramSpend.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's business segments — program spend.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's business segments — program spend?
PTC Therapeutics (PTCT) reported business segments — program spend of $37.54M in Q1 2026.
How has PTC Therapeutics's business segments — program spend changed year-over-year?
PTC Therapeutics's business segments — program spend decreased by 22.0% year-over-year, from $48.16M to $37.54M.
What is the long-term trend for PTC Therapeutics's business segments — program spend?
Over 3 years (2022 to 2025), PTC Therapeutics's business segments — program spend has grown at a -11.6% compound annual growth rate (CAGR), from $292.04M to $201.71M.
What does business segments — program spend mean?
This metric captures the total financial resources allocated to specific research, development, and clinical trial programs within the life science segment. It reflects the company's strategic commitment to advancing its pipeline and the intensity of its innovation efforts.